Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To coincide with Rare Disease Day, Dr Duantida Songdej (a consultant haematologist in Thailand) and her DPhil co-supervisor Dr Chris Babbs write about their work creating a registry of survivors of this rare form of anaemia.

Image courtesy of Wellcome

Thalassemia is an inherited blood disorder that results in the production of abnormal red blood cells, resulting in the inefficient transport of oxygen around the body. In severe cases, babies carrying the genetic changes that cause the disease rarely survive to birth and the health of the mother is also affected. However, recent improvements in medical care mean that now, babies with this rare form of severe anaemia can survive and this presents a need for sharing resources and expertise between doctors throughout the world to ensure these patients are properly cared for throughout life. 

Read more (The WIMM blog website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.